BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2470618)

  • 1. Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection.
    Hattori T; Koito A; Takatsuki K; Kido H; Katunuma N
    FEBS Lett; 1989 May; 248(1-2):48-52. PubMed ID: 2470618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neutralizing epitope of human immunodeficiency virus type 1 has homologous amino acid sequences with the active site of inter-alpha-trypsin inhibitor.
    Koito A; Hattori T; Murakami T; Matsushita S; Maeda Y; Yamamoto T; Takatsuki K
    Int Immunol; 1989; 1(6):613-8. PubMed ID: 2484964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New biological functions of intracellular proteases and their endogenous inhibitors as bioreactants.
    Katunuma N
    Adv Enzyme Regul; 1990; 30():377-92. PubMed ID: 2206023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 (human immunodeficiency virus-1) envelope glycoprotein.
    Harvima IT; Harvima RJ; Nilsson G; Ivanoff L; Schwartz LB
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):711-8. PubMed ID: 8318003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.
    Niwa Y; Yano M; Futaki S; Okumura Y; Kido H
    Eur J Biochem; 1996 Apr; 237(1):64-70. PubMed ID: 8620895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry.
    Schols D; Pauwels R; Baba M; Desmyter J; De Clercq E
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2397-408. PubMed ID: 2789268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast cells.
    Schwartz LB
    J Immunol; 1985 Jan; 134(1):526-31. PubMed ID: 2578051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of uninfected T-cells occurs with immature HIV-1 protease-mutant, but not morphologically similar protease inhibitor derived particles.
    Bahmani MK; Kameoka M; Goto T; Sano K; Luftig RB; Ikuta K
    Virus Res; 2000 Feb; 66(2):131-7. PubMed ID: 10725546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel membrane-bound serine esterase in human T4(+)-lymphocytes is a binding protein of envelope glycoprotein gp120 of HIV-1.
    Kido H; Fukutomi A; Katunuma N
    Biomed Biochim Acta; 1991; 50(4-6):781-9. PubMed ID: 1686971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 protease as a potential target for anti-AIDS therapy.
    Meek TD; Dreyer GB
    Ann N Y Acad Sci; 1990; 616():41-53. PubMed ID: 2078031
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel membrane-bound serine esterase in human T4+ lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1. Purification and characterization.
    Kido H; Fukutomi A; Katunuma N
    J Biol Chem; 1990 Dec; 265(35):21979-85. PubMed ID: 1979328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.
    Vahlne A; Horal P; Eriksson K; Jeansson S; Rymo L; Hedström KG; Czerkinsky C; Holmgren J; Svennerholm B
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10744-8. PubMed ID: 1961741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells.
    Ojo-Amaize EA; Nishanian P; Keith DE; Houghton RL; Heitjan DF; Fahey JL; Giorgi JV
    J Immunol; 1987 Oct; 139(7):2458-63. PubMed ID: 2821115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase.
    Kamoshita K; Shiota M; Sasaki M; Koga Y; Okumura Y; Kido H
    J Biochem; 1995 Jun; 117(6):1244-53. PubMed ID: 7490267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
    Matsushita S; Maeda H; Kimachi K; Eda Y; Maeda Y; Murakami T; Tokiyoshi S; Takatsuki K
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1107-15. PubMed ID: 1380258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells.
    Schwartz LB; Irani AM; Roller K; Castells MC; Schechter NM
    J Immunol; 1987 Apr; 138(8):2611-5. PubMed ID: 3549903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maleylated human serum albumin inhibits HIV-1 infection in vitro.
    Takami M; Sone T; Mizumoto K; Kino K; Tsunoo H
    Biochim Biophys Acta; 1992 Dec; 1180(2):180-6. PubMed ID: 1281431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates.
    Pinter A; Honnen WJ; Racho ME; Tilley SA
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):985-96. PubMed ID: 7506556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.